Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity

IntroductionOur research group and others demonstrated the implication of the human endogenous retroviruses (HERVs) in SARS-CoV-2 infection and their association with disease progression, suggesting HERVs as contributing factors in COVID-19 immunopathology. To identify early predictive biomarkers of...

Full description

Bibliographic Details
Main Authors: Vita Petrone, Marialaura Fanelli, Martina Giudice, Nicola Toschi, Allegra Conti, Christian Maracchioni, Marco Iannetta, Claudia Resta, Chiara Cipriani, Martino Tony Miele, Francesca Amati, Massimo Andreoni, Loredana Sarmati, Paola Rogliani, Giuseppe Novelli, Enrico Garaci, Guido Rasi, Paola Sinibaldi-Vallebona, Antonella Minutolo, Claudia Matteucci, Emanuela Balestrieri, Sandro Grelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1155624/full
_version_ 1827943035362607104
author Vita Petrone
Marialaura Fanelli
Martina Giudice
Nicola Toschi
Nicola Toschi
Allegra Conti
Christian Maracchioni
Marco Iannetta
Claudia Resta
Chiara Cipriani
Martino Tony Miele
Francesca Amati
Massimo Andreoni
Loredana Sarmati
Paola Rogliani
Giuseppe Novelli
Giuseppe Novelli
Giuseppe Novelli
Enrico Garaci
Guido Rasi
Paola Sinibaldi-Vallebona
Paola Sinibaldi-Vallebona
Antonella Minutolo
Claudia Matteucci
Emanuela Balestrieri
Sandro Grelli
Sandro Grelli
author_facet Vita Petrone
Marialaura Fanelli
Martina Giudice
Nicola Toschi
Nicola Toschi
Allegra Conti
Christian Maracchioni
Marco Iannetta
Claudia Resta
Chiara Cipriani
Martino Tony Miele
Francesca Amati
Massimo Andreoni
Loredana Sarmati
Paola Rogliani
Giuseppe Novelli
Giuseppe Novelli
Giuseppe Novelli
Enrico Garaci
Guido Rasi
Paola Sinibaldi-Vallebona
Paola Sinibaldi-Vallebona
Antonella Minutolo
Claudia Matteucci
Emanuela Balestrieri
Sandro Grelli
Sandro Grelli
author_sort Vita Petrone
collection DOAJ
description IntroductionOur research group and others demonstrated the implication of the human endogenous retroviruses (HERVs) in SARS-CoV-2 infection and their association with disease progression, suggesting HERVs as contributing factors in COVID-19 immunopathology. To identify early predictive biomarkers of the COVID-19 severity, we analyzed the expression of HERVs and inflammatory mediators in SARS-CoV-2-positive and -negative nasopharyngeal/oropharyngeal swabs with respect to biochemical parameters and clinical outcome.MethodsResiduals of swab samples (20 SARS-CoV-2-negative and 43 SARS-CoV-2-positive) were collected during the first wave of the pandemic and expression levels of HERVs and inflammatory mediators were analyzed by qRT-Real time PCR.ResultsThe results obtained show that infection with SARS-CoV-2 resulted in a general increase in the expression of HERVs and mediators of the immune response. In particular, SARS-CoV-2 infection is associated with increased expression of HERV-K and HERV-W, IL-1β, IL-6, IL-17, TNF-α, MCP-1, INF-γ, TLR-3, and TLR-7, while lower levels of IL-10, IFN-α, IFN-β, and TLR-4 were found in individuals who underwent hospitalization. Moreover, higher expression of HERV-W, IL-1β, IL-6, IFN-α, and IFN-β reflected the respiratory outcome of patients during hospitalization. Interestingly, a machine learning model was able to classify hospitalized vs not hospitalized patients with good accuracy based on the expression levels of HERV-K, HERV-W, IL-6, TNF-a, TLR-3, TLR-7, and the N gene of SARS-CoV-2. These latest biomarkers also correlated with parameters of coagulation and inflammation.DiscussionOverall, the present results suggest HERVs as contributing elements in COVID-19 and early genomic biomarkers to predict COVID-19 severity and disease outcome.
first_indexed 2024-03-13T10:09:24Z
format Article
id doaj.art-48d27bb09a824551806ea8541eaf86da
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-03-13T10:09:24Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-48d27bb09a824551806ea8541eaf86da2023-05-22T04:49:59ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-05-011410.3389/fmicb.2023.11556241155624Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severityVita Petrone0Marialaura Fanelli1Martina Giudice2Nicola Toschi3Nicola Toschi4Allegra Conti5Christian Maracchioni6Marco Iannetta7Claudia Resta8Chiara Cipriani9Martino Tony Miele10Francesca Amati11Massimo Andreoni12Loredana Sarmati13Paola Rogliani14Giuseppe Novelli15Giuseppe Novelli16Giuseppe Novelli17Enrico Garaci18Guido Rasi19Paola Sinibaldi-Vallebona20Paola Sinibaldi-Vallebona21Antonella Minutolo22Claudia Matteucci23Emanuela Balestrieri24Sandro Grelli25Sandro Grelli26Department of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, ItalyMartinos Center for Biomedical Imaging and Harvard Medical School, Boston, MA, United StatesDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyRespiratory Medicine Unit, Policlinic of Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyRespiratory Medicine Unit, Policlinic of Tor Vergata, Rome, ItalyDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, ItalyNeuromed IRCCS Institute, Pozzilli, IS, ItalyUniversity of Nevada, Department of Pharmacology, Reno, NV, United StatesIRCCS San Raffaele Pisana, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyNational Research Council, Institute of Translational Pharmacology, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy0Virology Unit, Policlinic of Tor Vergata, Rome, ItalyIntroductionOur research group and others demonstrated the implication of the human endogenous retroviruses (HERVs) in SARS-CoV-2 infection and their association with disease progression, suggesting HERVs as contributing factors in COVID-19 immunopathology. To identify early predictive biomarkers of the COVID-19 severity, we analyzed the expression of HERVs and inflammatory mediators in SARS-CoV-2-positive and -negative nasopharyngeal/oropharyngeal swabs with respect to biochemical parameters and clinical outcome.MethodsResiduals of swab samples (20 SARS-CoV-2-negative and 43 SARS-CoV-2-positive) were collected during the first wave of the pandemic and expression levels of HERVs and inflammatory mediators were analyzed by qRT-Real time PCR.ResultsThe results obtained show that infection with SARS-CoV-2 resulted in a general increase in the expression of HERVs and mediators of the immune response. In particular, SARS-CoV-2 infection is associated with increased expression of HERV-K and HERV-W, IL-1β, IL-6, IL-17, TNF-α, MCP-1, INF-γ, TLR-3, and TLR-7, while lower levels of IL-10, IFN-α, IFN-β, and TLR-4 were found in individuals who underwent hospitalization. Moreover, higher expression of HERV-W, IL-1β, IL-6, IFN-α, and IFN-β reflected the respiratory outcome of patients during hospitalization. Interestingly, a machine learning model was able to classify hospitalized vs not hospitalized patients with good accuracy based on the expression levels of HERV-K, HERV-W, IL-6, TNF-a, TLR-3, TLR-7, and the N gene of SARS-CoV-2. These latest biomarkers also correlated with parameters of coagulation and inflammation.DiscussionOverall, the present results suggest HERVs as contributing elements in COVID-19 and early genomic biomarkers to predict COVID-19 severity and disease outcome.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1155624/fullhuman endogenous retrovirusesHERVbiomarkerrespiratory outcomeinflammationCOVID-19
spellingShingle Vita Petrone
Marialaura Fanelli
Martina Giudice
Nicola Toschi
Nicola Toschi
Allegra Conti
Christian Maracchioni
Marco Iannetta
Claudia Resta
Chiara Cipriani
Martino Tony Miele
Francesca Amati
Massimo Andreoni
Loredana Sarmati
Paola Rogliani
Giuseppe Novelli
Giuseppe Novelli
Giuseppe Novelli
Enrico Garaci
Guido Rasi
Paola Sinibaldi-Vallebona
Paola Sinibaldi-Vallebona
Antonella Minutolo
Claudia Matteucci
Emanuela Balestrieri
Sandro Grelli
Sandro Grelli
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
Frontiers in Microbiology
human endogenous retroviruses
HERV
biomarker
respiratory outcome
inflammation
COVID-19
title Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
title_full Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
title_fullStr Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
title_full_unstemmed Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
title_short Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity
title_sort expression profile of hervs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of covid 19 severity
topic human endogenous retroviruses
HERV
biomarker
respiratory outcome
inflammation
COVID-19
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1155624/full
work_keys_str_mv AT vitapetrone expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT marialaurafanelli expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT martinagiudice expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT nicolatoschi expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT nicolatoschi expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT allegraconti expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT christianmaracchioni expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT marcoiannetta expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT claudiaresta expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT chiaracipriani expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT martinotonymiele expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT francescaamati expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT massimoandreoni expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT loredanasarmati expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT paolarogliani expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT giuseppenovelli expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT giuseppenovelli expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT giuseppenovelli expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT enricogaraci expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT guidorasi expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT paolasinibaldivallebona expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT paolasinibaldivallebona expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT antonellaminutolo expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT claudiamatteucci expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT emanuelabalestrieri expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT sandrogrelli expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity
AT sandrogrelli expressionprofileofhervsandinflammatorymediatorsdetectedinnasalmucosaasapredictivebiomarkerofcovid19severity